205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-7.85%
Negative revenue growth while MU stands at 11.44%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-6.35%
Negative gross profit growth while MU is at 36.50%. Joel Greenblatt would examine cost competitiveness or demand decline.
-11.23%
Negative EBIT growth while MU is at 107.55%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-11.23%
Negative operating income growth while MU is at 107.55%. Joel Greenblatt would press for urgent turnaround measures.
-22.75%
Negative net income growth while MU stands at 80.53%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-21.74%
Negative EPS growth while MU is at 69.49%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-23.91%
Negative diluted EPS growth while MU is at 69.49%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
-1.77%
Share reduction while MU is at 6.51%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-2.00%
Reduced diluted shares while MU is at 8.26%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
1.80%
Dividend growth of 1.80% while MU is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
-34.44%
Negative OCF growth while MU is at 29.88%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-40.57%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
49.18%
10Y revenue/share CAGR above 1.5x MU's 12.88%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
130.13%
5Y revenue/share CAGR at 50-75% of MU's 181.97%. Martin Whitman would worry about a lagging mid-term growth trajectory.
30.62%
3Y revenue/share CAGR above 1.5x MU's 14.19%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
101.41%
10Y OCF/share CAGR above 1.5x MU's 55.81%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
146.61%
Positive OCF/share growth while MU is negative. John Neff might see a comparative advantage in operational cash viability.
69.41%
3Y OCF/share CAGR above 1.5x MU's 38.91%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
323.19%
Net income/share CAGR above 1.5x MU's 199.87% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
1889.18%
5Y net income/share CAGR above 1.5x MU's 133.79%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
68.97%
Below 50% of MU's 8538.97%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
181.93%
10Y equity/share CAGR above 1.5x MU's 75.90%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
25.48%
Positive 5Y equity/share CAGR while MU is negative. John Neff might see a clear edge in retaining earnings or managing capital better.
12.20%
Below 50% of MU's 26.01%. Michael Burry suspects a serious short-term disadvantage in building book value.
91.76%
Dividend/share CAGR of 91.76% while MU is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
106.54%
Dividend/share CAGR of 106.54% while MU is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
88.39%
3Y dividend/share CAGR of 88.39% while MU is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
-1.01%
Firm’s AR is declining while MU shows 4.18%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-1.95%
Inventory is declining while MU stands at 15.68%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-1.29%
Negative asset growth while MU invests at 7.00%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
1.11%
Positive BV/share change while MU is negative. John Neff sees a clear edge over a competitor losing equity.
No Data
No Data available this quarter, please select a different quarter.
-0.72%
Our R&D shrinks while MU invests at 12.06%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-4.93%
We cut SG&A while MU invests at 25.26%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.